• LDS
  • /Medical Tests
  • /Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™)

Diseases (4)
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Overview
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Clinical Utility
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Interpretation
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Reference Ranges
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Methodology
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Specimen Collection
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Additional Testing
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Turnaround Time
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

CPT
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

LOINC
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

ICD10
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Additional ICD10
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

References
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.

Panel Test Components
Access to Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™) is restricted.